Dallas, TX -- (SBWIRE) -- 07/27/2010 -- ReportsandReports announce it will carry Abbott Laboratories Market Share Analysis Market Research Report in its Store.

Browse complete Report on: http://www.reportsandreports.com/market-reports/abbott-laboratories-market-share-analysis/

This report is an essential source for data, analysis and strategic insight into the medical equipment business of Abbott Laboratories. The report provides key information relating to Abbott Laboratories medical equipment revenue, market share by sector and country, financial and SWOT analysis of the company. The report examines the medical equipment business structure and operations, history and products, and provides an analysis of its key medical equipment revenue lines. It inspects the company’s strategic strengths and weaknesses.

Scope

• Revenues for the medical equipment markets and sub-sectors by country and region.

• Provides the share of market and sub sectors by country and region.

• Detailed breakdown revenues contributed by the medical equipment business operations.

• Provides summary of the medical equipment pipeline products that the company is developing.

• Critical analysis of the company’s strengths, weaknesses opportunities and threats.

• Provides summary analysis of key revenue lines and strategy.

• Details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions.

• Latest mergers and acquisitions, partnerships or financings of the company, including debt, equity or venture finance.

Reasons to buy

• A single source to fulfill all of your business and competitor intelligence needs
• Research your competitor’s business structure, strategy and prospects.
• Counter your competitor’s strengths and target their weaknesses.
• Identify your competitor’s key revenue streams by market and geography.
• Identify and assess potential corporate and investment opportunities.
• Support sales activities by understanding your customers businesses better.
• Identify potential competitor products before they reach market.
• Qualify prospective partners and suppliers.

1 Table of Contents
1.1 List of Tables 9
1.2 List of Figures 11

2 Introduction
2.1 What Is This Report About? 14

3 Definitions of Markets/Categories Covered
3.1 In Vitro Diagnostics 15
3.1.1 Clinical Chemistry 15
3.1.2 Genetic Testing 15
3.1.3 Haematology 15
3.1.4 Histology and Cytology 15
3.1.5 Immuno Chemistry 15
3.1.6 Infectious Immunology 15
3.2 Cardiovascular Devices 16
3.2.1 Interventional Cardiology 16
3.2.2 Peripheral Vascular Devices 16
3.3 Diabetes Care Devices 16
3.3.1 Glucose Monitoring 16

4 Company Snapshot
4.1 Key Information 17
4.2 Company Overview 17
4.3 Financial Performance 17
4.4 SWOT Snapshot 17

5 Business Description
5.1 Business Overview 18
5.2 Diagnostics 18
5.2.1 Overview 18
5.2.2 Financials 18
5.2.3 Market View 18
5.2.4 Key Strategies 18
5.3 Nutritionals 19
5.3.1 Overview 19
5.3.2 Financials 19
5.3.3 Market View 19
5.3.4 Key Strategies 19
5.4 Pharmaceuticals 19
5.4.1 Overview 19
5.4.2 Financials 19
5.4.3 Market View 19
5.4.4 Key Strategies 20
5.5 Vascular 20
5.5.1 Overview 20
5.5.2 Financials 20
5.5.3 Market View 20
5.5.4 Key Strategies 20
5.6 Major Products and Services 21
5.6.1 Overview 21

6 History

7 SWOT Analysis
7.1 Overview 27
7.2 Abbott Laboratories Strengths 28
7.2.1 Efficient Use of Resources 28
7.2.2 Strong Financial Performance 28
7.2.3 Diversified Geographic Presence 28
7.2.4 Diverse Product Portfolio 28
7.3 Abbott Laboratories Weaknesses 29
7.3.1 Product Recalls 29
7.3.2 Limited Liquidity Position 29
7.3.3 Legal Proceedings 29
7.4 Abbott Laboratories Opportunities 30
7.4.1 Expansion 30
7.4.2 Growing Aged Population 30
7.4.3 Market Growth in Emerging Economies 30
7.4.4 Growing Blood Glucose Monitoring Market 30
7.4.5 Strategic Acquisitions 31
7.5 Abbott Laboratories Threats 31
7.5.1 Increased Pricing Control 31
7.5.2 Tightening of the FDA’s Regulatory Oversight 31
7.5.3 Competitive Landscape 31
7.5.4 Technological Changes 32

8 Competitors

9 Competitive Landscape
9.1 In Vitro Diagnostics, Global, Company Share (%), 2009 34
9.2 Cardiovascular Devices, Global, Company Share (%), 2009 36
9.3 Diabetes Care Devices, Global, Company Share (%), 2009 38

10 Abbott Laboratories Medical Equipment Market Share Analysis
10.1 Abbott Laboratories, Global, Market Share (2009) 40
10.2 Abbott Laboratories, Asia-Pacific, Market Share (2009) 42
10.2.1 Abbott Laboratories, Australia, Market Share (2009) 44
10.2.2 Abbott Laboratories, China, Market Share (2009) 46
10.2.3 Abbott Laboratories, India, Market Share (2009) 48
10.2.4 Abbott Laboratories, Japan, Market Share (2009) 50
10.2.5 Abbott Laboratories, Other Asia-Pacific, Market Share (2009) 52
10.3 Abbott Laboratories, Europe, Market Share (2009) 54
10.3.1 Abbott Laboratories, France, Market Share (2009) 56
10.3.2 Abbott Laboratories, Germany, Market Share (2009) 58
10.3.3 Abbott Laboratories, Italy, Market Share (2009) 60
10.3.4 Abbott Laboratories, Spain, Market Share (2009) 62
10.3.5 Abbott Laboratories, United Kingdom, Market Share (2009) 64
10.3.6 Abbott Laboratories, Other Europe, Market Share (2009) 66
10.4 Abbott Laboratories, Middle East and Africa, Market Share (2009) 68
10.5 Abbott Laboratories, North America, Market Share (2009) 70
10.5.1 Abbott Laboratories, Canada, Market Share (2009) 72
10.5.2 Abbott Laboratories, United States, Market Share (2009) 74
10.6 Abbott Laboratories, South and Central America, Market Share (2009) 76
10.6.1 Abbott Laboratories, Brazil, Market Share (2009) 78
10.6.2 Abbott Laboratories, Other South and Central America, Market Share (2009) 80

11 Abbott Laboratories Medical Equipment Market Share Analysis by Category
11.1 Abbott Laboratories, Global, Category Revenue Share (2009) 82
11.2 Abbott Laboratories, Asia-Pacific, Category Revenue Share (2009) 85
11.2.1 Abbott Laboratories, Australia, Category Revenue Share (2009) 88
11.2.2 Abbott Laboratories, China, Category Revenue Share (2009) 91
11.2.3 Abbott Laboratories, India, Category Revenue Share (2009) 94
11.2.4 Abbott Laboratories, Japan, Category Revenue Share (2009) 97
11.2.5 Abbott Laboratories, Other Asia-Pacific, Category Revenue Share (2009) 100
11.3 Abbott Laboratories, Europe, Category Revenue Share (2009) 103
11.3.1 Abbott Laboratories, France, Category Revenue Share (2009) 106
11.3.2 Abbott Laboratories, Germany, Category Revenue Share (2009) 109
11.3.3 Abbott Laboratories, Italy, Category Revenue Share (2009) 112
11.3.4 Abbott Laboratories, Spain, Category Revenue Share (2009) 115
11.3.5 Abbott Laboratories, United Kingdom, Category Revenue Share (2009) 118
11.3.6 Abbott Laboratories, Other Europe, Category Revenue Share (2009) 121
11.4 Abbott Laboratories, Middle East and Africa, Category Revenue Share (2009) 124
11.5 Abbott Laboratories, North America, Category Revenue Share (2009) 127
11.5.1 Abbott Laboratories, Canada, Category Revenue Share (2009) 130
11.5.2 Abbott Laboratories, United States, Category Revenue Share (2009) 133
11.6 Abbott Laboratories, South and Central America, Category Revenue Share (2009) 136
11.6.1 Abbott Laboratories, Brazil, Category Revenue Share (2009) 139
11.6.2 Abbott Laboratories, Other South and Central America, Category Revenue Share (2009) 142

12 Key Employees

13 Key Employee Biographies

14 Company Statement

15 Locations And Subsidiaries
15.1 Head Office 151
15.2 Other Locations & Subsidiaries 151

16 Financial Deals Landscape
16.1 Abbott Laboratories, Deals Volume Summary, 2005 to YTD 2010 154

17 Abbott Laboratories Detailed Deal Summary
17.1 Asset Purchase 158
17.1.1 Boston Scientific To Sell Pain Management Unit 158
17.2 Partnerships 160
17.2.1 Fujirebio Diagnostics Signs Licensing Agreement with Abbott Laboratories 160
17.2.2 Rubicon Genomics Enters Into An Agreement With Abbott Laboratories 161
17.3 Acquisition 162
17.3.1 Abbott Laboratories Acquires Evalve 162
17.3.2 Abbott Laboratories Completes Acquisition of Visiogen 164

18 Recent Developments
18.1 Strategy and Business Planning 166
18.1.1 May 05, 2010: Abbott Opens Asia-Pacific Nutrition Research And Development Center In Singapore 166
18.1.2 Nov 17, 2009: Abbott Signs Agreement With BG Medicine For Development Of Heart Failure Test 166
18.1.3 Nov 15, 2009: Abbott Enters Into Agreement With PanGenetics 167
18.1.4 Nov 12, 2009: Abbott To Acquire PanGenetics BV's NGF Inhibitor To Treat Chronic Pain 167
18.1.5 Nov 12, 2009: Abbott To Acquire PanGenetics' Investigational Antibody To Treat Chronic Pain 167
18.1.6 Aug 27, 2009: Abbott Enters Into Agreement With Pfizer 168
18.1.7 Aug 18, 2009: Abbott Signs Partnership Agreement With Velcera For Pain Drug 168
18.2 Financial Announcements 169
18.2.1 Apr 21, 2010: Abbott Reports Net Earnings Of $1 Billion In Q1 2010 169
18.2.2 Jan 27, 2010: Abbott Reports Net Earnings Of $5.7 Million In 2009 169
18.2.3 Oct 14, 2009: Abbott Reports Net Earnings Of $1.5 Billion In Q3 2009 171
18.2.4 Oct 14, 2009: Abbott Q3 2009 Net Income Increases By 36.5% 172
18.3 Research and Development 173
18.3.1 Oct 23, 2009: Abbott Launches New R&D Facility At University of Illinois 173
18.4 Corporate Communications 173
18.4.1 Dec 03, 2009: Abbott Lays off about 80 Jobs at Its Temecula Factory, California 173
18.5 Legal and Regulatory 173
18.5.1 May 05, 2010: Watson Confirms SIMCOR Patent Challenge 173
18.5.2 Nov 11, 2009: Arnold & Itkin Announces Lawsuits Over Defective Pain Pumps 174
18.5.3 Aug 26, 2009: New Jersey Doctor Files Patent Lawsuit Against Abbott Over Heart Stents 174
18.6 Government and Public Interest 175
18.6.1 Apr 15, 2010: Abbott Begins Biopreparedness Evaluation Program with State Public Health Labs 175
18.6.2 Nov 17, 2009: FDA Warns Abbott on Manufacturing Practices At Des Plaines Facility 176
18.6.3 Nov 16, 2009: Federal Sales Tax on Medical Devices Would Cost Millions 176
18.6.4 Oct 20, 2009: FDA Grants 510(k) Clearance To Abbott For Cyclic-Citrulinated Peptide 176
18.6.5 Sep 14, 2009: SFDA Approves Abbott's XIENCE V Drug Eluting Stent 177
18.6.6 Sep 14, 2009: Abbott Obtains European Approval For Kaletra Tablet 177
18.6.7 Sep 14, 2009: Abbott Obtains European Approval For Once-daily Dosing of Kaletra Tablet 177
18.7 Product News 178
18.7.1 Jun 03, 2010: Abbott Receives FDA Clearance For ARCHITECT HE4 Assay 178
18.7.2 May 19, 2010: Abbott Receives BLA Approval From FDA For ABBOTT PRISM Chagas Test 178
18.7.3 Apr 30, 2010: Abbott Receives FDA Approval For Abbott Prism Chagas 179
18.7.4 Apr 30, 2010: FDA Announces Class II Recall Of Abbott’s Freestyle Navigator Continuous Glucose Monitor System 179
18.7.5 Feb 08, 2010: Abbott Files FDA 510(K) Application For ARCHITECT HE4 Assay 179
18.7.6 Jan 14, 2010: Abbott Gains CE Mark For New Ovarian Cancer Diagnostic Test 180
18.7.7 Sep 18, 2009: Abbott Receives FDA Approval For Prism HIV O Plus Assay 180
18.7.8 Sep 15, 2009: Abbott Gains Top Honor In Wall Street Journal Technology Innovation Awards for Its PLEX-ID 180
18.8 Product Approvals 181
18.8.1 Jun 03, 2010: Abbott Receives FDA Clearance For ARCHITECT HE4 Assay 181
18.8.2 May 19, 2010: Abbott Receives BLA Approval From FDA For ABBOTT PRISM Chagas Test 182
18.8.3 Apr 30, 2010: Abbott Receives FDA Approval For Abbott Prism Chagas 182
18.8.4 Jan 14, 2010: Abbott Gains CE Mark For New Ovarian Cancer Diagnostic Test 182
18.8.5 Sep 18, 2009: Abbott Receives FDA Approval For Prism HIV O Plus Assay 184
18.9 Other Significant Developments 184
18.9.1 Jan 13, 2010: Abbott to Provide $1 Million In Funding, Products To Help Address Health Needs In Haiti 184
18.9.2 Nov 02, 2009: Abbott Saves 1 Billion Gallons of Water Annually 185
18.9.3 Oct 14, 2009: Abbott Reports 36.5% Surge in Q3 Earnings 186
18.9.4 Sep 16, 2009: Abbott Expands Use Of Sustainable Packaging As Part Of Global Environmental Efforts 186

19 Appendix
19.1 Research Methodology 189
19.2 Secondary Research 190
19.3 Primary Research 190
19.4 Models 191
19.5 Forecasts 191
19.6 Expert Panels 191
19.7 GlobalData Consulting 191
19.8 Currency Conversion 192
19.9 Contact Us 193
19.10 Disclaimer 193

Browse complete Report on: http://www.reportsandreports.com/market-reports/abbott-laboratories-market-share-analysis/

Browse all Medical Devices Market Research Reports on:
http://www.reportsandreports.com/market-research/medical-devices/

Browse all GlobalData Market Research Reports on:
http://www.reportsandreports.com/Publishers/globaldata/

Browse all Latest Report on:
http://www.reportsandreports.com/LatestReport.aspx

Related Reports:

Abbott Medical Optics, Inc. Market Share Analysis
http://www.reportsandreports.com/market-reports/abbott-medical-optics-inc-market-share-analysis/

Abbott Laboratories - SWOT Analysis
http://www.reportsandreports.com/market-reports/abbott-laboratories-swot-analysis/

Abbott Laboratories: PharmaVitae Profile
http://www.reportsandreports.com/market-reports/abbott-laboratories-pharmavitae-profile/

About Reports and Reports
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/
Blog: http://reportsandreports.blogspot.com/